Publications
Detailed Information
Sensitive and specific detection of low-level antibody responses in mild Middle East respiratory syndrome coronavirus infections
Cited 63 time in
Web of Science
Cited 66 time in Scopus
- Authors
- Issue Date
- 2019-10
- Citation
- Emerging Infectious Diseases, Vol.25 No.10, pp.1868-1877
- Abstract
- Middle East respiratory syndrome coronavirus (MERS-CoV) infections in humans can cause asymptomatic to fatal lower respiratory lung disease. Despite posing a probable risk for virus transmission, asymptomatic to mild infections can go unnoticed; a lack of seroconversion among some PCR-confirmed cases has been reported. We found that a MERS-CoV spike S1 protein-based ELISA, routinely used in surveillance studies, showed low sensitivity in detecting infections among PCR-confirmed patients with mild clinical symptoms and cross-reactivity of human coronavirus OC43-positive serum samples. Using in-house S1 ELISA and protein microarray, we demonstrate that most PCR-confirmed MERS-CoV case-patients with mild infections seroconverted; nonetheless, some of these samples did not have detectable levels of virus-neutralizing antibodies. The use of a sensitive and specific serologic Si-based assay can be instrumental in the accurate estimation of MERS-CoV prevalence.
- ISSN
- 1080-6040
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.